Clinical Trial Update: Hemorrhage Risk Prescribed Arixtra

View source ↗

Summary

A completed clinical trial evaluated the risk of hemorrhage with the anticoagulant Arixtra (fondaparinux) in venous thrombosis, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombosis, Venous | Status: COMPLETED | Results posted: 2011-02-11